Clinical Trial Update: MR Elastography of Cognitive Impairment

View source ↗

Summary

A Mayo Clinic trial evaluating MR elastography as a biomarker for Alzheimer's disease and mild cognitive impairment is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Mayo Clinic | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: ENROLLING_BY_INVITATION